Investment ThemesDetailed Quotes
Weight Loss Drugs
Watchlist
GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
- 1668.374
- +32.920+2.01%
Close Nov 7 16:00 ET
1670.977High1641.906Low
1645.456Open1635.454Pre Close72.59MVolume6Rise60.78P/E (Static)6.96BTurnover1Flatline0.69%Turnover Ratio1.58TMarket Cap--Fall1.44TFloat Cap
Constituent Stocks: 7Top Rising: VKTX+4.52%
$Ford Motor (F.US)$
$Eli Lilly and Co (LLY.US)$
You see that yellow line. once closing below that it will be like stepping on a landmine!
Just taking a breather for Friday opinion clearing.
Larger Image: tradingview.com...
$Altimmune (ALT.US)$
...
Altimmune Announces Successful Completion of End-of-Phase 2 Meeting with FDA for Pemvidutide in the Treatment of Obesity
Altimmune (Nasdaq: ALT) announced successful completion of End-of-Phase 2 Meeting with FDA for pemvidutide in obesity treatment. The company received agreement on Phase 3 registrational program design, which will include four Phase 3 trials (VELOCITY-1,2,3,4) enrolling approximately 5,000 subjects over 60-week periods. The trials will evaluate pemvidut...
watch it fall
No comment yet